Expert opinion on priority risk groups for influenza vaccination
This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.
Programmatic management of latent tuberculosis infection in the European Union
Programmatic management of latent tuberculosis infection (LTBI) is a key component of the global tuberculosis (TB) elimination strategy. This document provides evidence-based guidance for the implementation of programmatic management of LTBI in the European Union and European Economic Area (EU/EEA).
COVID-19 Rail Protocol: Recommendations for safe resumption of railway services in Europe
The European Union Agency’s for Railways (ERA), the European Commission and the European Centre for Disease Prevention and Control (ECDC) have developed the following COVID-19 railway protocol, outlining the operational guidelines for the resumption of railway operations in Europe.
Systematic review on the diagnosis, treatment, care and prevention of tuberculosis in prison settings
The objective of this report is to systematically review data on the diagnosis, treatment, care and prevention of tuberculosis in prison settings, with a focus on the countries of the European Union and the European Economic Area.
Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
COVID-19 in children and the role of school settings in COVID-19 transmission
The aim of this document is to provide an overview of the epidemiology and disease characteristics of COVID-19 in children (0-18 years) in EU/EEA countries and the United Kingdom (UK), and an assessment of the role of childcare (preschools; ages 0-<5 years) and educational (primary and secondary schools; ages 5-18 years) settings in COVID-19 transmission.
Public health guidance on investigation and control of tuberculosis incidents affecting children in congregate settings
This report aims to bring the different components of generic outbreak management and tuberculosis specific policies and guidelines together, to develop a more comprehensive package of guidance to capture the elements that are specific for TB incidents affecting children in congregate settings.
Public health guidance on chlamydia control in Europe
This document outlines the steps necessary to implement a comprehensive and effective control programme. It also offers advice on how to monitor and evaluate such programmes in order to ensure their effectiveness.
Projected baselines of COVID-19 in the EU/EEA and the UK for assessing the impact of de-escalation of measures
This report aims to provide a short-term 30-day forecast of the expected number of COVID-19 cases, deaths and hospitalised cases (including general hospital ward and intensive care unit) under a set of assumptions.
Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - First update
This first update of the original document is prompted by the recent scientific developments and evolution of the coronavirus 2019 (COVID-19) pandemic and the need to include types of substances of human origin (SoHO) that were not addressed in the first version (e.g. reproductive and some non-reproductive tissues and cells).